Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
1.57B
Enterprise Value
1.93B
Income
53.13M
Sales
3.91B
Book/sh
17.37
Cash/sh
8.03
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3000
IPO
Oct 23, 2006
P/E
29.58
Forward P/E
16.45
PEG
0.21
P/S
0.40
P/B
1.82
P/C
3.95
P/FCF
15.81
EV/EBITDA
10.46
EV/Sales
0.49
Quick Ratio
1.25
Current Ratio
1.25
Debt/Eq
1.14
LT Debt/Eq
1.06
Option/Short
Yes / Yes
EPS (ttm)
1.07
EPS next Y
1.93
EPS next Q
0.25
EPS this Y
187.41%
EPS next Y
45.77%
EPS next 5Y
77.49%
EPS past 3/5Y
-22.81% -14.74%
Sales past 3/5Y
40.62% 35.87%
EPS Y/Y TTM
463.11%
Sales Y/Y TTM
35.05%
EPS Q/Q
3360.00%
Sales Q/Q
7.07%
Insider Own
23.50%
Insider Trans
0.00%
Inst Own
66.39%
Inst Trans
4.78%
ROA
2.32%
ROE
6.51%
ROIC
3.01%
Gross Margin
9.34%
Oper. Margin
3.10%
Profit Margin
1.36%
SMA20
-14.00%
SMA50
-13.80%
SMA200
-7.20%
Trades
Shs Outstand
49.32M
Shs Float
37.95M
52W High
51.60 -38.58%
52W Low
18.08 75.30%
Volatility
9.32% 5.32%
ATR (14)
2.17
RSI (14)
32.38
Beta
1.25
Rel Volume
0.88
Avg Volume
387.37K
Volume
106,542
Perf Week
-13.71%
Perf Month
-17.46%
Perf Quarter
-11.44%
Perf Half Y
-18.75%
Perf YTD
27.75%
Perf Year
41.30%
Perf 3Y
4.95%
Perf 5Y
-67.57%
Perf 10Y
922.39%
Prev Close
33.77
Price
31.69
Change %
-6.15%
Consensus
Strong Buy
Avg. Price Target
$52.11
Implied Upside
+64.4%
Analysts14incl. previous ratings
Rating Distribution13 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 15, 2026Initiated
OPY logoOOppenheimer
Outperform$53+67.2%
May 26, 2026Upgrade
BCS logoBBarclays
Equal Weight → Overweight$50+57.8%
Dec 12, 2025Initiated
NNeedham
Buy$28-11.7%
Apr 01, 2025Initiated
BCS logoBBarclays
Equal Weight$36+13.6%
Oct 14, 2024Initiated
TD logoTTD Cowen
Buy$66+108.2%
Oct 11, 2024Initiated
KEY logoKKeyBanc Capital Markets
Sector Weight
Jul 11, 2024Upgrade
TFC logoTTruist
Hold → Buy$44 → $50+57.8%
May 30, 2024Initiated
RRobert W. Baird
Outperform$54+70.4%
Feb 26, 2024Initiated
JEF logoJJefferies
Buy$50+57.8%
Feb 22, 2024Upgrade
BAC logoBBofA Securities
Neutral → Buy$44 → $55+73.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schmidt DavidDirectorAug 14 '26Option Exercise5.0020,000100,00056,019Aug 18 04:15 PM
Sim BrandonCEO and PresidentFeb 02 '26Option Exercise23.2421,334495,8021,045,329Feb 03 09:37 PM
Schmidt DavidDirectorJan 13 '26Option Exercise5.7920,000115,80035,763Jan 15 04:15 PM
Lam Thomas S.DirectorDec 08 '25Option Exercise17.7829,502524,546459,122Dec 10 04:15 PM
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.
M.D.Dr. Kenneth T. Sim F.A.C.S.
President & CEOMr. Brandon K. Sim M.S.
M.P.H.Dr. Thomas S. Lam M.D.
CFOMr. Chandan Basho M.B.A.
CGMAMr. John Vong CPA